Portfolio (Quarterly)
Guide ↗
Bellevue Group AG
· CIK 0001674546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 5,005,719.0 | $398.7M | 7.56% | NEW | — | $79.65 | +88.7% |
| 2 | ARGX | ARGENX SE | Healthcare | 461,854.0 | $388.4M | 7.36% | NEW | — | $840.95 | -2.9% |
| 3 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 4,802,199.0 | $379.9M | 7.20% | NEW | — | $79.11 | -4.2% |
| 4 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 681,120.0 | $308.8M | 5.85% | NEW | — | $453.36 | -5.1% |
| 5 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 1,703,304.0 | $241.6M | 4.58% | NEW | — | $141.83 | +9.6% |
| 6 | — | AVIDITY BIOSCIENCES INC | — | 2,630,969.0 | $189.8M | 3.60% | NEW | — | $72.13 | — |
| 7 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 322,028.0 | $182.4M | 3.46% | NEW | — | $566.36 | -22.3% |
| 8 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 4,056,592.0 | $178.7M | 3.39% | NEW | — | $44.05 | +9.8% |
| 9 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 445,903.0 | $177.3M | 3.36% | NEW | — | $397.65 | -24.4% |
| 10 | ABT | ABBOTT LABS | Healthcare | 1,316,915.0 | $165.0M | 3.13% | NEW | — | $125.29 | -29.9% |
| 11 | FOLD | AMICUS THERAPEUTICS INC | Healthcare | 10,735,195.0 | $152.9M | 2.90% | NEW | — | $14.24 | +1.8% |
| 12 | BSX | BOSTON SCIENTIFIC CORP | Healthcare | 1,559,606.0 | $148.7M | 2.82% | NEW | — | $95.35 | -40.1% |
| 13 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 4,358,527.0 | $135.6M | 2.57% | NEW | — | $31.12 | -43.3% |
| 14 | SYK | STRYKER CORPORATION | Healthcare | 360,577.0 | $126.7M | 2.40% | NEW | — | $351.47 | -8.5% |
| 15 | NUVL | NUVALENT INC | Healthcare | 1,037,468.0 | $104.4M | 1.98% | NEW | — | $100.59 | +0.6% |
| 16 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 410,323.0 | $101.2M | 1.92% | NEW | — | $246.54 | +23.4% |
| 17 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 3,617,669.0 | $98.3M | 1.86% | NEW | — | $27.16 | +12.6% |
| 18 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 2,796,803.0 | $97.1M | 1.84% | NEW | — | $34.71 | -13.6% |
| 19 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 1,043,096.0 | $88.9M | 1.69% | NEW | — | $85.25 | -2.4% |
| 20 | VERA | VERA THERAPEUTICS INC | Healthcare | 1,698,152.0 | $86.0M | 1.63% | NEW | — | $50.64 | -31.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.3%
Consumer Cyclical
0.1%
Financial Services
0.1%
Communication Services
0.0%
Consumer Defensive
0.0%